Financial Data and Key Metrics Changes - Revenue increased by 8% to $2.9 million compared to $2.7 million a year ago, reflecting steady execution and year-over-year progress [12] - Gross profit rose to $1.9 million, maintaining a strong gross margin of 66%, relatively unchanged year-over-year [12] - Operating expenses were reported at $3.7 million, up from $3.4 million in the prior year, leading to an operating loss of $1.7 million compared to $1.6 million last year [13] - Net loss after preferred stock dividends was $1.7 million, or $2.21 per share, versus a net loss of $1.6 million, or $3,732 per share in the prior year period [13] Business Line Data and Key Metrics Changes - Strong sales to VA partners and a shift towards B2B channels contributed to performance, with significant progress in the VA and government segment [4][5] - New product launches included medicine reminders and activity metrics, enhancing the company's proactive analytics capabilities [5][6] Market Data and Key Metrics Changes - The company is focusing on expanding its VA and government relationships, strengthening B2B distributor networks, and improving direct-to-consumer channels [10][17] - A national safety survey indicated that trust, simplicity, and visibility are key factors for customers when choosing personal safety systems, validating the company's market direction [9] Company Strategy and Development Direction - The company is evolving its business model from standalone device sales to a comprehensive platform that includes subscription monitoring and predictive analytics [3] - Priorities include increasing adoption of bundled monitoring and subscription services, advancing the AI-enabled care platform, and optimizing go-to-market execution [10][17] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to deliver progress with a solid balance sheet and increasing revenue [17] - The focus remains on executing a targeted business plan with clear priorities, particularly in the VA and government sectors [10][17] Other Important Information - The company has filed 44 patent applications, with 24 issued, strengthening its position as an innovator in personal safety and care technology [8] - The company is currently trading under the symbol LGMKD on the OTC market, with plans to resume trading under the old ticker symbol LGMK [14] Q&A Session Summary - No questions were raised during the Q&A session, and the call concluded with closing remarks from management [16][18]